Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02095756 · ClinicalTrials.gov registry record · NA
Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02095756 is a NA study that has completed, run by Cynosure. The registered enrollment target is 20 participants.
The verdict
NCT02095756, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of a combination of non-hydroquinone topical therapy and a 755nm Alexandrite compared to topical therapy alone for the treatment of facial melasma.
Interventions
- OTHER 755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy)
- OTHER Lytera Skin Brightening System (Non-hydroquinone topical therapy)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02095756
The ClinicalTrials.gov registry entry for NCT02095756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy) is the first listed.
NCT02095756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02095756 about?
NCT02095756 is a clinical study titled "Combination Alexandrite Laser and Topical Therapy vs Topical Therapy Alone for Treatment of Melasma". The purpose of this study is to evaluate the efficacy and safety of a combination of non-hydroquinone topical therapy and a 755nm Alexandrite compared to topical therapy alone for the treatment of facial melasma.
What is the current status of trial NCT02095756?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02095756?
The interventions under investigation include: 755nm Alexandrite Laser and Lytera Skin Brightening System (Non-Hydroquinone Topical Therapy) (OTHER), Lytera Skin Brightening System (Non-hydroquinone topical therapy) (OTHER).
Who is sponsoring clinical trial NCT02095756?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.